Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Research
Apply to the Influential Medicine Providing Access to Clinical Trials (IMPACT) Program
Expanding access to high-quality clinical trials to patients served by community health settings, particularly rural, minority, and/or economically di…
Research
Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds Over PLN 250 Million ($57M USD)
Krakow, Poland – December 22, 2022 – Ryvu Therapeutics [WSE:RVU], a clinical-stage drug discovery and development company focusing on novel small mole…
News
FDA Approves the First-in-Class Bispecific Antibody for Treatment of Follicular Lymphoma
“This new treatment has the potential to help patients with this hard-to-treat cancer achieve remission,” says LLS Chief Scientific Officer Dr. Lee Gr…
Patient Education Webcasts
LLS Fireside Chats for Parents and Caregivers of Young Patients
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
